ARCA biopharma, Inc.

NasdaqCM:ABIO Stock Report

Market Cap: US$51.9m

ARCA biopharma Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqCM:ABIO Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
03 Apr 24BuyUS$4,047,578Adage Capital Management, L.P.Company1,200,000US$3.90

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of ABIO?
Owner TypeNumber of SharesOwnership Percentage
Private Companies3,0230.0208%
Individual Insiders147,1191.01%
General Public2,531,67817.5%
Institutions3,143,71221.7%
Hedge Funds8,675,61159.8%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 82.53% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
27.6%
Cable Car Capital LLC
4,000,452US$14.3m0%20.69%
9.72%
Western Standard, LLC
1,410,143US$5.0m20.1%4.58%
8.28%
Adage Capital Management, L.P.
1,200,000US$4.3m0%0.01%
7.45%
Janus Henderson Group plc
1,080,107US$3.9m0%no data
7.34%
Allostery Investments LP
1,065,016US$3.8m0%no data
6.9%
Avidity Partners Management, L.P.
1,000,000US$3.6m0%0.14%
4.88%
BML Capital Management, LLC
706,930US$2.5m0%1.77%
3.13%
The Vanguard Group, Inc.
453,598US$1.6m0.68%no data
1.86%
Newtyn Management, LLC
269,320US$964.2k-10.2%0.13%
1.6%
BlackRock, Inc.
231,911US$830.2k-0.02%no data
0.98%
Geode Capital Management, LLC
142,349US$509.6k0%no data
0.49%
State Street Global Advisors, Inc.
71,137US$254.7k0%no data
0.4%
Renaissance Technologies LLC
57,299US$205.1k12.8%no data
0.35%
Christopher Ozeroff
50,970US$182.5k0%no data
0.34%
Robert Conway
50,000US$179.0k0%no data
0.29%
Dimensional Fund Advisors LP
42,514US$152.2k0%no data
0.28%
C. Dekker
40,000US$143.2k0%no data
0.22%
abrdn plc
32,461US$116.2k0%no data
0.14%
Northern Trust Global Investments
20,982US$75.1k0%no data
0.1%
Charles Schwab Investment Management, Inc.
14,988US$53.7k0%no data
0.084%
Two Sigma Securities, LLC, Asset Management Arm
12,119US$43.4k0%no data
0.044%
Citadel Advisors LLC
6,320US$22.6k0%no data
0.033%
Michael Bristow
4,808US$17.2k0%no data
0.021%
Tower Research Capital LLC
3,023US$10.8k-18.1%no data
0.0078%
UBS Asset Management AG
1,131US$4.0k805%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.